These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1372 related articles for article (PubMed ID: 33687468)

  • 21. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.
    Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS
    Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits and harms of CT screening for lung cancer: a systematic review.
    Bach PB; Mirkin JN; Oliver TK; Azzoli CG; Berry DA; Brawley OW; Byers T; Colditz GA; Gould MK; Jett JR; Sabichi AL; Smith-Bindman R; Wood DE; Qaseem A; Detterbeck FC
    JAMA; 2012 Jun; 307(22):2418-29. PubMed ID: 22610500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Bowles EJA; Williams SB; Morrison CC
    JAMA; 2017 May; 317(18):1888-1903. PubMed ID: 28492904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Crotty K; Yun JDY; Middleton JC; Feltner C; Taylor-Phillips S; Barclay C; Dotson A; Baker C; Balio CP; Voisin CE; Harris RP
    JAMA; 2021 Aug; 326(8):744-760. PubMed ID: 34427595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
    Aberle DR; Abtin F; Brown K
    J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New evidence supporting lung cancer screening with low dose CT & surgical implications.
    Dezube AR; Jaklitsch MT
    Eur J Surg Oncol; 2020 Jun; 46(6):982-990. PubMed ID: 32113886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
    Ebell MH; Bentivegna M; Hulme C
    Ann Fam Med; 2020 Nov; 18(6):545-552. PubMed ID: 33168683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force.
    Slatore CG; Baumann C; Pappas M; Humphrey LL
    Ann Am Thorac Soc; 2014 May; 11(4):619-27. PubMed ID: 24701999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
    Caverly TJ; Cao P; Hayward RA; Meza R
    Ann Intern Med; 2018 Jul; 169(1):1-9. PubMed ID: 29809244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Lung Cancer Screening.
    Brownlee AR; Donington JS
    Semin Respir Crit Care Med; 2020 Jun; 41(3):447-452. PubMed ID: 32450597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting.
    Kaaks R; Delorme S
    Rofo; 2021 May; 193(5):527-536. PubMed ID: 33212540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.